Literature DB >> 12918857

Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation.

Mathias H Wilhelmi1, Heike Mertsching, Michaela Wilhelmi, Rainer Leyh, Axel Haverich.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Biological heart valve prostheses undergo degenerative changes which lead ultimately to dysfunction or even complete destruction. The study aim was to evaluate immunological factors and their potential role in biological heart valve destruction.
METHODS: Allogeneic (n = 10) and xenogeneic (n = 3) aortic valve prostheses, as well as aortic valves retrieved from transplanted human hearts which had to be replaced due to chronic graft rejection (n = 4), were analyzed. Aortic valves from human donor hearts (n = 4) served as controls. Evaluated adhesion molecule expression included: selectin family ELAM-1, CD62; integrin family VLA-1, -2, -3, -4, -5 and -6; immuoglobulin supergene family PECAM-1, ICAM-1 and -2, and class I heavy chain proteins; complementary adhesion molecules CD34, CD44 and von Willebrand factor.
RESULTS: ELAM-1, ICAM-1 and -2, CD34, CD44 and class I heavy chain proteins, which play significant roles during inflammatory processes, showed stronger expression patterns in allogeneic and xenogeneic aortic heart valve prostheses compared to native or chronically rejected valves. Furthermore, allogeneic and xenogeneic valves showed a strong thrombogenicity which stained positive for von Willebrand factor outside endothelial cells on these valves. Integrin molecules as well as CD62 showed only mild differences.
CONCLUSION: Immunological reactions play a pivotal role in the degeneration of biological heart valve prostheses. As immunosuppressive therapy after heart valve replacement is not a viable option, novel approaches in 'tissue engineering' may help to avoid tissue degeneration while preserving the advantage of biological tissue origin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918857

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  5 in total

Review 1.  In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.

Authors:  Benjamin Smood; Hidetaka Hara; David C Cleveland; David K C Cooper
Journal:  Ann Thorac Surg       Date:  2019-03-02       Impact factor: 4.330

Review 2.  Bioprosthetic heart valves of the future.

Authors:  Rizwan A Manji; Burcin Ekser; Alan H Menkis; David K C Cooper
Journal:  Xenotransplantation       Date:  2014-01-21       Impact factor: 3.907

3.  Genomic and proteomic investigation of preeclampsia.

Authors:  Hayrettin Sahin; Tuba Gunel; Ali Benian; Evren Onay Ucar; Onur Guralp; Aydinli Kilic
Journal:  Exp Ther Med       Date:  2015-05-21       Impact factor: 2.447

Review 4.  In Situ "Humanization" of Porcine Bioprostheses: Demonstration of Tendon Bioprostheses Conversion into Human ACL and Possible Implications for Heart Valve Bioprostheses.

Authors:  Uri Galili; Kevin R Stone
Journal:  Bioengineering (Basel)       Date:  2021-01-12

5.  Tumor necrosis factor alpha-an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?

Authors:  Moritz Mirna; Mario Holnthoner; Albert Topf; Peter Jirak; Dzeneta Fejzic; Vera Paar; Jörg Kellermair; Hermann Blessberger; Christian Reiter; Jürgen Kammler; Lukas J Motloch; Christian Jung; Daniel Kretzschmar; Marcus Franz; Brunilda Alushi; Alexander Lauten; Uta C Hoppe; Clemens Steinwender; Michael Lichtenauer
Journal:  J Clin Lab Anal       Date:  2021-09-25       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.